Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
HELP for NOWS Consortium
Study ID
NCT07278375
Status
Recruiting

Conditions

  • Neonatal Opioid Withdrawal Syndrome

Eligibility Criteria

Sex
ALL
Age
0 Minutes - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to learn how two medicines used in routine care-buprenorphine and morphine-affect recovery in newborns (≥36 weeks' gestation) with Neonatal Opioid Withdrawal Syndrome (NOWS). The main questions it aims to answer are: 1. Do infants treated with buprenorphine become medically ready for discharge sooner than those treated with morphine? 2. Does one treatment lead to better overall clinical outcomes than the other? Researchers will compare infants who received buprenorphine with infants who received morphine to see whether one treatment helps babies recover more quickly. Participants will not be asked to do anything. Instead, the study team will collect information already documented in the infant's and mother's medical records securely without any contact or changes to clinical care. No new medicines, procedures, or visits are involved. This study only reviews existing clinical data to better understand which commonly used treatment may support faster recovery for newborns with NOWS.

Key Dates

Start date
Dec 9, 2025
Status verified
Feb 2026
Primary completion
Jun 19, 2026
Completion
Aug 30, 2026

Study Design

Enrollment
796 participants (estimated)

Arms

  • Arm: Infants treated with buprenorphine
    Infants treated with buprenorphine as the primary opioid for NOWS
  • Arm: Infants treated with morphine
    Infants treated with morphine as the primary opioid for NOWS

Primary Outcome Measure

Time from birth until infant meets criteria for medically ready for discharge (count) [ Time Frame: From date of birth until date of infant meeting criteria for medically ready for discharge (estimated to be < 90 days). ]

Central Contacts

Locations (22)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35294
Namasivayam Ambalavanan, MD
Namasivayam Ambalavanan, MD (PRINCIPAL_INVESTIGATOR)
University of Arkansas for Medical SciencesLittle RockArkansas72205-7199
Richard W Hall, MD
501-686-8000
Richard W Hall, MD (PRINCIPAL_INVESTIGATOR)
ChristianaCareWilmingtonDelaware19801
Kelley Kovatis, MD
215-427-5000
Kelley Z Kovatis, MD (PRINCIPAL_INVESTIGATOR)
University of South Florida HealthTampaFlorida33606
Tanner Wright, MD, FAAP
321-217-2235
Tanner Wright, MD, FAAP (PRINCIPAL_INVESTIGATOR)
Riley Hospital for Children at IU HealthIndianapolisIndiana46202-5119
Gregory Sokol, MD
317-274-8021
Gregory Sokol, MD (PRINCIPAL_INVESTIGATOR)
Sidney & Lois Eskenazi HospitalIndianapolisIndiana46202
Gregory Sokol, MD
317-274-8021
Gregory Sokol, MD (PRINCIPAL_INVESTIGATOR)
University of Louisville HospitalJeffersonvilleIndiana47130
Lori Devlin, DO, MHA, MS
502-852-8470
Lori Devlin, DO, MHA, MS (PRINCIPAL_INVESTIGATOR)
St. Elizabeth HealthcareEdgewoodKentucky41017
Stephanie Merhar, MD, MS
513-803-5180
Stephanie Merhar, MD, MS (PRINCIPAL_INVESTIGATOR)
Kentucky Children's HospitalLexingtonKentucky40536
Thitinart Sithisarn, MD, PhD
859-257-6481
Thitinart Sithisarn, MD, PhD, FAAP (PRINCIPAL_INVESTIGATOR)
Norton Children's HospitalLouisvilleKentucky40202
Lori Devlin, DO, MHA, MS
502-852-8470
Lori Devlin, DO, MHA, MS (PRINCIPAL_INVESTIGATOR)
Norton Women's and Children's HospitalLouisvilleKentucky40207
Lori Devlin, DO, MHA, MS
502-852-8470
Lori Devlin, DO, MHA, MS (PRINCIPAL_INVESTIGATOR)
Children's Regional Hospital, Cooper University Health CareCamdenNew Jersey08103
Alla Kushnir, MD, FAAP
856-342-2265
Alla Kushnir, MD, FAAP (PRINCIPAL_INVESTIGATOR)
University of New Mexico Health Sciences CenterAlbuquerqueNew Mexico87131
Lawrence Leeman, MD, MPH
505-272-2165
Lawrence M Leeman, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of Rochester Medical CenterRochesterNew York14642
Joseph Bliss, MD, PhD
585-275-9767
Joseph Bliss, MD, PhD (PRINCIPAL_INVESTIGATOR)
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229
Stephanie Merhar, MD, MS
513-803-5180
Stephanie Merhar, MD, MS (PRINCIPAL_INVESTIGATOR)
Good Samaritan HospitalCincinnatiOhio45202
Stephanie Merhar, MD, MS
513-803-5180
Stephanie Merhar, MD, MS (PRINCIPAL_INVESTIGATOR)
Rainbow Babies and Children's HospitalClevelandOhio44106
Moira Crowley, MD
216-844-3759
Moira Crowley, MD (PRINCIPAL_INVESTIGATOR)
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Scott Lorch, MD, MSCE
215-590-1653
Scott Lorch, MD, MSCE (PRINCIPAL_INVESTIGATOR)
Pennsylvania HospitalPhiladelphiaPennsylvania19107
Karen Puopolo, MD, PhD
215-829-3301
Karen Puopolo, MD, PhD (PRINCIPAL_INVESTIGATOR)
Thomas Jefferson University HospitalPhiladelphiaPennsylvania19107
Walter Kraft, MD
501-686-8000
Walter K Kraft, MD (PRINCIPAL_INVESTIGATOR)
University of Utah HealthSalt Lake CityUtah84158
Bhanu Muniyappa, MD
801-581-2205
Bhanu Muniyappa, MD (PRINCIPAL_INVESTIGATOR)
University of Vermont Medical CenterBurlingtonVermont05401
Adrienne Pahl, MD
802-847-2700
Adrienne Pahl, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

Related Studies